Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
QUANTRX BIOMEDICAL CORP (QTXB) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/21/2017 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "Asset Purchase Agreement",
"Patent Assignment",
"Trademark Assignment",
"License Agreement",
"Escrow Agreement",
"Warrant"
03/26/2015 8-K Quarterly results
03/04/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Source: QuantRx Biomedical Corporation"
02/25/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "QuantRx® Biomedical Provides Update on Corporate Developments TUALATIN, OR-- - QuantRx® Biomedical Corporation , an emerging provider of innovative healthcare solutions for feminine care, point-of-care diagnostics, laboratory diagnostics and genomic testing, all of which leverage its robust portfolio of patented intellectual property, is pleased to announce continued progress and exciting development across its business lines. The Company is pursuing manufacturing capacity for the domestic production of its distinctive patented miniform pads . A reliable, high-quality supply of Pads will enable the Company to aggressively drive online sales of both its untreated miniform pads for the feminine care market and treated miniform pads for feminine inflammatory conditions. In addition to the lar..."
03/01/2012 8-K Form 8-K - Current report
11/07/2011 8-K Form 8-K - Current report
07/14/2011 8-K Form 8-K - Current report
07/08/2011 8-K Entry into a Material Definitive Agreement, Other Events
Docs: "SETTLEMENT AGREEMENT AND RELEASE"
01/03/2011 8-K Form 8-K - Current report
09/01/2010 8-K Form 8-K - Current report
07/22/2010 8-K Termination of a Material Definitive Agreement
06/09/2010 8-K Form 8-K - Current report
05/06/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "QuantRx Biomedical Announces Board of Directors Updates Company Mourns Passing of Board Member Arthur Hull Hays, Jr; Appoints Two New Independent Directors"
01/29/2010 8-K Form 8-K - Current report
08/05/2009 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
05/11/2009 8-K Form 8-K - Current report
12/18/2008 8-K Form 8-K -- Current report
08/27/2008 8-K Form 8-K -- Current report
08/20/2008 8-K Entry into a Material Definitive Agreement
07/28/2008 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Senior Secured Bridge Note, dated June 2008 and maturing September 15, 2008, issued by QuantRx in favor of lender",
"Form of Warrant to Purchase Shares of Common Stock of QuantRx, dated June 2008, issued by QuantRx in favor of lender",
"Form of Bridge Letter Loan Agreement, dated June 2008, between QuantRx and lender",
"Form of Stock Pledge Agreement, dated June 2008, between QuantRx and lender",
"Form of Patent, Trademark and Copyright Security Agreement, dated June 2008, between QuantRx and lender"
02/29/2008 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
01/29/2008 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
12/31/2007 8-K Termination of a Material Definitive Agreement
10/24/2007 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Senior Convertible Promissory Note, dated October __, 2007, from QuantRx Biomedical Corporation in favor of Investor",
"Form of Letter Loan Agreement, dated October __, 2007, between Investor and QuantRx Biomedical Corporation",
"Form of Warrant to Purchase Shares of Common Stock of QuantRx Biomedical Corporation, dated October __, 2007"
04/19/2007 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Stage 2 Investment Agreement, between QuantRx Biomedical Corporation and FluoroPharma, Inc",
"QuantRx(R) Biomedical Acquires Majority Interest In FluoroPharma"
03/07/2007 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "QUANTRX(R) BIOMEDICAL COMPLETES FINAL PHASE OF EQUITY FINANCING, RAISING AN ADDITIONAL $3.53 MILLION FOR AGGREGATE PROCEEDS OF $5.57 MILLION"
12/12/2006 8-K Entry into a Material Definitive Agreement
Docs: "Common Stock and Warrant Purchase Agreement, among QuantRx Biomedical Corporation and the purchasers specified therein",
"Form of Warrant",
"Registration Rights Agreement, among QuantRx Biomedical Corporation and the purchasers specified therein",
"QUANTRX(R) BIOMEDICAL STRENGTHENS FINANCIAL POSITION"
09/08/2006 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
07/13/2006 8-K Entry into a Material Definitive Agreement
03/16/2006 8-K Entry into a Material Definitive Agreement
02/17/2006 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
12/12/2005 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
11/10/2005 8-K Unregistered Sales of Equity Securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy